Legal & General Group Plc - SILVERBACK THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of SILVERBACK THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$106,434
-36.4%
28,157
+12.7%
0.00%
Q2 2023$167,360
-60.2%
24,979
-61.3%
0.00%
Q1 2023$420,175
+6902.9%
64,543
+3830.8%
0.00%
Q1 2022$6,000
-45.5%
1,6420.0%0.00%
Q4 2021$11,000
-70.3%
1,642
-55.8%
0.00%
Q3 2021$37,000
+15.6%
3,711
+255.8%
0.00%
Q2 2021$32,000
-43.9%
1,043
-20.3%
0.00%
Q1 2021$57,000
+5600.0%
1,308
+9961.5%
0.00%
Q4 2020$1,000130.00%
Other shareholders
SILVERBACK THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 4,012,903$15,168,7737.77%
Nextech Invest Ltd. 1,910,029$7,219,9102.19%
K2 PRINCIPAL FUND, L.P. 2,552,062$9,646,7942.02%
Charles Schwab Trust Co 4,246,071$16,050,1481.81%
Sio Capital Management, LLC 1,105,911$4,180,3441.29%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 11,077,927$41,874,5640.92%
SECTORAL ASSET MANAGEMENT INC 1,049,191$3,965,9420.77%
Orbimed Advisors 9,240,887$34,930,5530.74%
RA Capital Management 9,459,678$35,757,5830.70%
K2 PRINCIPAL FUND, L.P. 688,900$2,604,0420.55%
View complete list of SILVERBACK THERAPEUTICS INC shareholders